The effect of geographic access on severe health outcomes for pediatric asthma

被引:30
|
作者
Garcia, Erin [1 ]
Serban, Nicoleta [1 ]
Swann, Julie [1 ,2 ]
Fitzpatrick, Anne [3 ]
机构
[1] Georgia Inst Technol, H Milton Stewart Sch Ind & Syst Engn, Atlanta, GA 30332 USA
[2] Georgia Inst Technol, Sch Publ Policy, Atlanta, GA 30332 USA
[3] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA
基金
美国国家科学基金会;
关键词
Geographic access; pediatric asthma; severe health outcomes; POTENTIAL SPATIAL ACCESS; CHILDHOOD ASTHMA; AIR-POLLUTION; CARE PHYSICIANS; NEW-YORK; CHILDREN; ACCESSIBILITY; QUALITY; PREVALENCE; SERVICES;
D O I
10.1016/j.jaci.2015.01.030
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Access to medical care and severe pediatric asthma outcomes vary with geography, but the relationship between them has not been studied. Objective: We sought to evaluate the relationship between geographic access and health outcomes for pediatric asthma. Methods: The severe outcome measures include emergency department (ED) visits and hospitalizations for children with an asthma diagnosis in Georgia and North Carolina. We quantify asthma prevalence, outcome measures, and factors included in the statistical model using multiple data sources. We calculate geographic access to primary and asthma specialist care using optimization models. We estimate the association between outcomes and geographic access in the presence of other factors using logistic regression. The model is used to project the reduction in severe outcomes with improvement in access. Results: The association between access and outcomes for pediatric asthma depends on the type of outcome measure, type of care, and variations in other factors. The expression of this association is also different for the 2 states. Access to primary care plays a larger role than access to specialist care in explaining Georgia ED visits, whereas the reverse applies for hospitalizations. In North Carolina access to both primary and specialist care are statistically significant in explaining the variability in ED visits. Conclusions: The variation in the association between estimated access and outcomes affects the projected reductions of severe outcomes with access improvement. Thus applying one intervention would not have the same level of improvement across geography. Interventions must be tailored to target regions with the potential to deliver the highest effect to gain maximum benefit.
引用
收藏
页码:610 / 618
页数:9
相关论文
共 50 条
  • [21] Longitudinal Effect of Ambient Air Pollution and Pollen Exposure on Asthma Control: The Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Asthma Study
    Li, Zheng
    Xu, Xiaohui
    Thompson, Lindsay A.
    Gross, Heather E.
    Shenkman, Elizabeth A.
    DeWalt, Darren A.
    Huang, I-Chan
    ACADEMIC PEDIATRICS, 2019, 19 (06) : 615 - 623
  • [22] Do not forget asthma comorbidities in pediatric severe asthma!
    Ronco, Lucia
    Folino, Anna
    Goia, Manuela
    Crida, Benedetta
    Esposito, Irene
    Bignamini, Elisabetta
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [23] Lost in the transition from pediatric to adult healthcare? Experiences of young adults with severe asthma
    Odling, Maria
    Jonsson, Marina
    Janson, Christer
    Melen, Erik
    Bergstrom, Anna
    Kull, Inger
    JOURNAL OF ASTHMA, 2020, 57 (10) : 1119 - 1127
  • [24] Severe Asthma and Allergy: A Pediatric Perspective
    Arasi, Stefania
    Porcaro, Federica
    Cutrera, Renato
    Fiocchi, Alessandro G.
    FRONTIERS IN PEDIATRICS, 2019, 7
  • [25] Severe pediatric asthma therapy: Dupilumab
    Ferrante, Giuliana
    Tenero, Laura
    Piazza, Michele
    Piacentini, Giorgio
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [26] Severe Pediatric Asthma Therapy: Mepolizumab
    Ullmann, Nicola
    Peri, Francesca
    Florio, Olivia
    Porcaro, Federica
    Profeti, Elisa
    Onofri, Alessandro
    Cutrera, Renato
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [27] Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent allergic asthma
    Nieto Garcia, Antonio
    Garriga-Baraut, Teresa
    Plaza Martin, Ana Maria
    Nieto Cid, Maria
    Torres Borrego, Javier
    Folque Gimenez, Maria del Mar
    Lozano Blasco, Jaime
    Bosque Garcia, Montserrat
    Moreno-Galarraga, Laura
    Tortajada-Girbes, Miguel
    Rivas Juesas, Cristina
    Penin Anton, Maria
    Caballero-Rabasco, Maria Araceli
    Gaboli, Mirella
    Lopez Neyra, Alejandro
    Navarro Moron, Juan
    Freixa Benavente, Andrea
    Valdesoiro Navarrete, Laura
    Ballester Asensio, Esther
    Sanz Santiago, Veronica
    Romero Garcia, Raquel
    Gimeno Diaz de Atauri, Alvaro
    Valenzuela Soria, Alfredo
    Sanchez Mateos, Mercedes
    Batlles Garrido, Jose
    Andres Martin, Anselmo
    Campos Alonso, Elena
    Aragon Fernandez, Carmen
    Vazquez Rodriguez, Elena
    Martinez Pardo, Luz
    Del-Rio Camacho, Genoveva
    Mazon Ramos, Angel
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2021, 32 (05) : 980 - 991
  • [28] Improving Pediatric Asthma Outcomes in a Community Emergency Department
    Walls, Theresa A.
    Hughes, Naomi T.
    Mullan, Paul C.
    Chamberlain, James M.
    Brown, Kathleen
    PEDIATRICS, 2017, 139 (01)
  • [29] Urban Decay and Pediatric Asthma Prevalence in Memphis, Tennessee: Urban Data Integration for Efficient Population Health Surveillance
    Shin, Eun Kyong
    Shaban-Nejad, Arash
    IEEE ACCESS, 2018, 6 : 46281 - 46289
  • [30] Fatigue in severe pediatric asthma patients: Results of the PANDA study
    van Dijk, Yoni E.
    Keuker, Valerie S. L.
    Hashimoto, Simone
    Rutjes, Niels W.
    van Muilekom, Maud M.
    Golebski, Kornel
    Van Litsenburg, Raphaele R. L.
    Terheggen-Lagro, Suzanne W. J.
    van Ewijk, Bart E.
    Gemke, Reinoud J. B. J.
    Zee, Anke H. Maitland-van der
    Vijverberg, Susanne J. H.
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2024, 35 (10)